Reyna S - Search Results

1

Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice.

Meinking TL, Vicaria M, Eyerdam DH, Villar ME, Reyna S, Suarez G. Meinking TL, et al. Among authors: reyna s. Pediatr Dermatol. 2004 Nov-Dec;21(6):670-4. doi: 10.1111/j.0736-8046.2004.21613.x. Pediatr Dermatol. 2004. PMID: 15575855 Clinical Trial.

2

A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice.

Meinking TL, Vicaria M, Eyerdam DH, Villar ME, Reyna S, Suarez G. Meinking TL, et al. Among authors: reyna s. Pediatr Dermatol. 2007 Jul-Aug;24(4):405-11. doi: 10.1111/j.1525-1470.2007.00460.x. Pediatr Dermatol. 2007. PMID: 17845167 Clinical Trial.

3

The clinical trials supporting benzyl alcohol lotion 5% (Ulesfia): a safe and effective topical treatment for head lice (pediculosis humanus capitis).

Meinking TL, Villar ME, Vicaria M, Eyerdam DH, Paquet D, Mertz-Rivera K, Rivera HF, Hiriart J, Reyna S. Meinking TL, et al. Among authors: reyna s. Pediatr Dermatol. 2010 Jan-Feb;27(1):19-24. doi: 10.1111/j.1525-1470.2009.01059.x. Pediatr Dermatol. 2010. PMID: 20199404 Clinical Trial.

4

Erratum to: Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment.

McGrattan KE, Shell RD, Hurst-Davis R, Young SD, O'Brien E, Lavrov A, Wallach S, LaMarca N, Reyna SP, Darras BT. McGrattan KE, et al. Among authors: reyna sp. J Neuromuscul Dis. 2023;10(5):985-986. doi: 10.3233/JND-239002. J Neuromuscul Dis. 2023. PMID: 37661906 Free PMC article. No abstract available.

5

Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trial.

Shell RD, McGrattan KE, Hurst-Davis R, Young SD, Baranello G, Lavrov A, O'Brien E, Wallach S, LaMarca N, Reyna SP, Darras BT. Shell RD, et al. Among authors: reyna sp. Neuromuscul Disord. 2023 Aug;33(8):670-676. doi: 10.1016/j.nmd.2023.06.005. Epub 2023 Jun 22. Neuromuscul Disord. 2023. PMID: 37455203 Free article.

6

Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment.

McGrattan KE, Shell RD, Hurst-Davis R, Young SD, O'Brien E, Lavrov A, Wallach S, LaMarca N, Reyna SP, Darras BT. McGrattan KE, et al. Among authors: reyna sp. J Neuromuscul Dis. 2023;10(4):531-540. doi: 10.3233/JND-221531. J Neuromuscul Dis. 2023. PMID: 37092232 Free PMC article.

7

Triterpenoid CDDO-EA inhibits lipopolysaccharide-induced inflammatory responses in skeletal muscle cells through suppression of NF-κB.

Chang PF, Acevedo D, Mandarino LJ, Reyna SM. Chang PF, et al. Among authors: reyna sm. Exp Biol Med (Maywood). 2023 Jan;248(2):175-185. doi: 10.1177/15353702221139188. Epub 2023 Jan 20. Exp Biol Med (Maywood). 2023. PMID: 36661241 Free PMC article.

8

Safety of Onasemnogene Abeparvovec for Patients With Spinal Muscular Atrophy 8.5 kg or Heavier in a Global Managed Access Program.

Chand DH, Mitchell S, Sun R, LaMarca N, Reyna SP, Sutter T. Chand DH, et al. Among authors: reyna sp. Pediatr Neurol. 2022 Jul;132:27-32. doi: 10.1016/j.pediatrneurol.2022.05.001. Epub 2022 May 10. Pediatr Neurol. 2022. PMID: 35605311 Free article.

9

Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH. Day JW, et al. Among authors: reyna sp. Drug Saf. 2022 Feb;45(2):191-192. doi: 10.1007/s40264-021-01130-7. Drug Saf. 2022. PMID: 34940960 Free PMC article. No abstract available.

10

Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH. Day JW, et al. Among authors: reyna sp. Drug Saf. 2021 Oct;44(10):1109-1119. doi: 10.1007/s40264-021-01107-6. Epub 2021 Aug 12. Drug Saf. 2021. PMID: 34383289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page